Literature DB >> 15832595

Development of adenocarcinoma in chronic fistula in Crohn's disease.

S Laurent1, A Barbeaux, B Detroz, O Detry, E Louis, J Belaiche, M Meurisse.   

Abstract

The authors report the case of a 55 yr-old woman suffering from Crohn's disease since 31 years with stricture and fistulas developed in the ileocolic junction and anorectal portion. Long-standing anorectal fistulas and stricture led to adenocarcinoma and finally fistulisation in the vagina. Diagnosis was made by perineal examination with biopsies under general anaesthesia. Treatment was first posterior pelvectomy with resection of the anterior wall of vagina. Secondarily, radiochemotherapy was administrated. The authors discuss the incidence and risk factors of carcinoma in Crohn's disease with chronic fistulas.

Entities:  

Mesh:

Year:  2005        PMID: 15832595

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  4 in total

1.  Mucinous carcinoma in Crohn's disease originating in a fistulous tract.

Authors:  Hugh J Freeman; Tom Perry; Douglas L Webber; Silvia D Chang; Mong-Yang Loh
Journal:  World J Gastrointest Oncol       Date:  2010-07-15

2.  Adenocarcinoma in an ano-vaginal fistula in Crohn's disease.

Authors:  Maryam Alfa-Wali; Angela Atinga; Yasser Mohsen; Andrew Anthony; Alistair Myers
Journal:  Int J Surg Case Rep       Date:  2013-04-18

Review 3.  Malignant transformation in perianal fistulas of Crohn's disease: a systematic review of literature.

Authors:  Mathew Thomas; Robert Bienkowski; Thomas J Vandermeer; Douglas Trostle; Burt Cagir
Journal:  J Gastrointest Surg       Date:  2009-10-14       Impact factor: 3.452

4.  Clinicopathological characteristics of cancer associated with Crohn's disease.

Authors:  Hirofumi Sasaki; Hiroki Ikeuchi; Toshihiro Bando; Kei Hirose; Akihiro Hirata; Teruhiro Chohno; Yuki Horio; Naohiro Tomita; Seiichi Hirota; Yoshihiro Ide; Yasuaki Tsuchida; Motoi Uchino
Journal:  Surg Today       Date:  2016-04-19       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.